Definigen company
Our iPSC disease modeling services and platform will help you generate a range of metabolic and rare disease phenotypes for all your research needs!
Investors
%20.jpg)
%20.jpg)
Founded Date:
7-4
Last Funding Type:
Venture - Series Unknown
Headquarters:
Cambridge, UK
Investors Number:
7
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Regenerative Medicine
Estimated Revenue:
$1M to $10M
Number Of Exists:
Venture - Series Unknown
Funding Status:
N/A
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
£5.8M